Shahan has over 15 years of industrial experience of building scalable cross-functional teams, developing and architecting high performance computing systems, Shahan joins Phenotypeca as a CIO. His interests include bioinformatics and industry 4.0. Shahan holds a M.Sc. in Software Engineering with special emphasis on Enterprise Software Architecture.
Leadership
Ranjit Bhabra
Ranjit joins Phenotypeca as Finance Director with 36 years’ experience in financial, commercial and operational leadership with large multi-nationals and SMEs, across the globe. He is very experienced in scaling businesses within the engineering, software, project and services markets. He has driven a start-up business in the UK from circa £0.5m to over £50m over a 7-year period and has many years of experience in dealing with acquisitions, disposals and raising investment / finance.
Professor Ed Louis
Ed has a PhD in Genetics from The University of California at Berkeley, and a BSc in Biology and Mathematics from Clarkson University. He is experienced in yeast genetics, genomics, and evolution; was a key part of the yeast genome sequencing project; and is now developing tools for exploiting its natural genetic/phenotypic variation.
Dr Chris Finnis
PhD in Microbial Genetics from the University of Nottingham, MSc in Biochemical Engineering (UCL), Biotechnology BSc (Hons) from University of Leeds. 30-years industrial experience in yeast strain development for recombinant protein production. Royal Society Entrepreneur-in-Residence and inventor on multiple patents with a passion for bringing new products to the market.
Johnny Cordiner
Over 20 years of C-suite life sciences leadership. Johnny was formerly CEO and CFO of Lamellar Biomedical and also led the spin-out e-Therapeutics plc from Newcastle University and thereafter the raising of over $50 million of investment across 5 investment rounds including taking the company public. He is a chemistry and physics graduate, a chartered accountant with previous experience in IPO, M&A, product development, research projects, product commercialisation as well as patent strategy.